Table 4. Epicardial signature gene expression changes in muscle after myocardial infarction.

p-value	GenBank accession	Gene Symbol	Gene Description
0.0497	BB558905	Bace2	beta-site APP-cleaving enzyme 2
0.0495	NM_033314	Slco2a1	solute carrier organic anion transporter family, member 2a1
0.0473	NM_009242	Sparc	secreted acidic cysteine rich glycoprotein
0.0433	BF235516	Ptprf	protein tyrosine phosphatase, receptor type, F
0.0433	AK011545	Basp1///LOC100045716	brain abundant, membrane attached signal protein 1///similar to 22 kDa neuronal tissue-enriched acidic protein
0.0359	BB065799	Sulf1	sulfatase 1
0.0329	U08020	Col1a1	collagen, type I, alpha 1
0.0329	L36062	Star	steroidogenic acute regulatory protein
0.0329	NM_010329	Pdpn	podoplanin
0.0259	BF227507	Col1a2	collagen, type I, alpha 2
0.0211	AW550625	Col3a1	collagen, type III, alpha 1
0.0211	NM_011254	Rbp1	retinol binding protein 1, cellular
0.0211	NM_009636	Aebp1	AE binding protein 1
0.0175	BB392676	1500015O10Rik	RIKEN cDNA 1500015O10 gene
0.0175	NM_011985	Mmp23	matrix metallopeptidase 23
0.0175	NM_013586	Loxl3	lysyl oxidase-like 3
0.0175	X16834	Lgals3	lectin, galactose binding, soluble 3
0.0174	BC022666	Mfap4	microfibrillar-associated protein 4
0.0147	BC008107	Timp1	tissue inhibitor of metalloproteinase 1
0.00893	M65143	Lox	lysyl oxidase
0.00742	BC025600	Tmem119	transmembrane protein 119

Epicardial signature genes of Cluster 4 (from Figure 3) were tested for statistically significant upregulation in the muscle control samples as described in Materials and Methods. This Table shows those genes that were upregulated (p value cut off: 0.005) in the muscle control samples.